{"transactions":[{"id":963454,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-18T15:34:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":30681,"price":6.66,"value":204335.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $6.64 to $6.69. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5614457,"source":{"system":"sec-edgar","filing":"0001493152-25-028303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225028303/ownership.xml","form_type":"4"}},{"id":963453,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-18T15:34:54.000Z","date":"2025-11-24","kind":"other","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5645138,"source":{"system":"sec-edgar","filing":"0001493152-25-028303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225028303/ownership.xml","form_type":"4"}},{"id":978018,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-08T18:21:15.000Z","date":"2025-12-03","kind":"sale","planned":false,"acquired":false,"shares":132069,"price":5.73,"value":756755.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $5.68 to $5.85. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5670138,"source":{"system":"sec-edgar","filing":"0001493152-25-026587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225026587/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-04"}},{"id":978017,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-08T18:21:15.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":5.47,"value":164100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $5.40 to $5.50. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5802207,"source":{"system":"sec-edgar","filing":"0001493152-25-026587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225026587/ownership.xml","form_type":"4/A","original_submission_date":"2025-12-04"}},{"id":980571,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T21:57:00.000Z","date":"2025-12-03","kind":"sale","planned":false,"acquired":false,"shares":120000,"price":5.73,"value":687600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $5.68 to $5.85. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5682207,"source":{"system":"sec-edgar","filing":"0001493152-25-026204","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225026204/ownership.xml","form_type":"4"}},{"id":980570,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T21:57:00.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":5.47,"value":164100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $5.40 to $5.50. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5802207,"source":{"system":"sec-edgar","filing":"0001493152-25-026204","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225026204/ownership.xml","form_type":"4"}},{"id":1002551,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:33:48.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":5.25,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5832207,"source":{"system":"sec-edgar","filing":"0001493152-25-021959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225021959/ownership.xml","form_type":"4"}},{"id":1013943,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-25T00:18:00.000Z","date":"2025-10-22","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":4.94,"value":148200.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5872207,"source":{"system":"sec-edgar","filing":"0001493152-25-019379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225019379/ownership.xml","form_type":"4"}},{"id":1013942,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-25T00:18:00.000Z","date":"2025-10-22","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":4.93,"value":98600.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5902207,"source":{"system":"sec-edgar","filing":"0001493152-25-019379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225019379/ownership.xml","form_type":"4"}},{"id":1020434,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T22:27:00.000Z","date":"2024-04-23","kind":"sale","planned":false,"acquired":false,"shares":3677,"price":3.06,"value":11251.62,"ownership":{"direct":false,"nature":"By 10X Fund, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":5922207,"source":{"system":"sec-edgar","filing":"0001493152-25-017839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225017839/ownership.xml","form_type":"5"}},{"id":1020433,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T22:27:00.000Z","date":"2024-04-22","kind":"sale","planned":false,"acquired":false,"shares":21323,"price":3.06,"value":65248.38,"ownership":{"direct":false,"nature":"By 10X Fund, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":5925884,"source":{"system":"sec-edgar","filing":"0001493152-25-017839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315225017839/ownership.xml","form_type":"5"}},{"id":2040549,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T19:51:56.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":61407,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5947207,"source":{"system":"sec-edgar","filing":"0001493152-23-003128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315223003128/ownership.xml","form_type":"5"}},{"id":2040548,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T19:51:56.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":3077,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6008614,"source":{"system":"sec-edgar","filing":"0001493152-23-003128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315223003128/ownership.xml","form_type":"5"}},{"id":2040547,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T19:51:56.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":16050,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6011691,"source":{"system":"sec-edgar","filing":"0001493152-23-003128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315223003128/ownership.xml","form_type":"5"}},{"id":2040546,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T19:51:56.000Z","date":"2022-12-21","kind":"other","acquired":false,"shares":17117,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6027741,"source":{"system":"sec-edgar","filing":"0001493152-23-003128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315223003128/ownership.xml","form_type":"5"}},{"id":2040545,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T19:51:56.000Z","date":"2022-07-29","kind":"other","acquired":false,"shares":90586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6044858,"source":{"system":"sec-edgar","filing":"0001493152-23-003128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315223003128/ownership.xml","form_type":"5"}},{"id":2040544,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T19:51:56.000Z","date":"2022-07-29","kind":"other","acquired":false,"shares":33496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his/her/its pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6135444,"source":{"system":"sec-edgar","filing":"0001493152-23-003128","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315223003128/ownership.xml","form_type":"5"}},{"id":2185838,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T19:03:53.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":10000,"price":2.087,"value":20870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6168940,"source":{"system":"sec-edgar","filing":"0001493152-22-022804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315222022804/ownership.xml","form_type":"4/A","original_submission_date":"2022-08-09"}},{"id":2191208,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T19:01:58.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":10000,"price":2.087,"value":20870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6168940,"source":{"system":"sec-edgar","filing":"0001493152-22-021740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315222021740/ownership.xml","form_type":"4"}},{"id":2411895,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-04T23:23:24.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":10000,"price":2.1,"value":21000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6178940,"source":{"system":"sec-edgar","filing":"0001493152-22-003302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315222003302/ownership.xml","form_type":"4"}},{"id":2436127,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-13T20:42:07.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":10000,"price":2.1,"value":21000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6188940,"source":{"system":"sec-edgar","filing":"0001493152-22-001148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315222001148/ownership.xml","form_type":"4"}},{"id":2484098,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-06T17:42:51.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":10000,"price":2.37,"value":23700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6198940,"source":{"system":"sec-edgar","filing":"0001493152-21-030546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221030546/ownership.xml","form_type":"4"}},{"id":2524857,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-04T15:55:59.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":10000,"price":3.19,"value":31900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6208940,"source":{"system":"sec-edgar","filing":"0001493152-21-027207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221027207/ownership.xml","form_type":"4"}},{"id":2539647,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-19T19:18:14.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":10000,"price":3.37,"value":33700.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6218940,"source":{"system":"sec-edgar","filing":"0001493152-21-025776","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221025776/ownership.xml","form_type":"4"}},{"id":2547430,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-06T16:00:47.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":10000,"price":3.62,"value":36200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6228940,"source":{"system":"sec-edgar","filing":"0001493152-21-024757","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221024757/ownership.xml","form_type":"4"}},{"id":2579872,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-03T13:00:28.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":10000,"price":3.91,"value":39100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6238940,"source":{"system":"sec-edgar","filing":"0001493152-21-021935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221021935/ownership.xml","form_type":"4"}},{"id":2618264,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":2,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":3,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T19:48:36.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":10000,"price":3.25,"value":32500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6248940,"source":{"system":"sec-edgar","filing":"0001493152-21-018420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221018420/ownership.xml","form_type":"4"}},{"id":2633325,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":2,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":3,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-15T18:27:45.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":10000,"price":3.54,"value":35400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6258940,"source":{"system":"sec-edgar","filing":"0001493152-21-016934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221016934/ownership.xml","form_type":"4"}},{"id":2684011,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:27:17.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":10000,"price":3.91,"value":39100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6268940,"source":{"system":"sec-edgar","filing":"0001493152-21-013547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221013547/ownership.xml","form_type":"4"}},{"id":2727780,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T16:05:49.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":10000,"price":3.84,"value":38400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6278940,"source":{"system":"sec-edgar","filing":"0001493152-21-010480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010480/ownership.xml","form_type":"4/A","original_submission_date":"2021-05-04"}},{"id":2727779,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T16:05:49.000Z","date":"2021-04-28","kind":"sale","acquired":false,"shares":10000,"price":5.02,"value":50200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6288940,"source":{"system":"sec-edgar","filing":"0001493152-21-010480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010480/ownership.xml","form_type":"4/A","original_submission_date":"2021-05-04"}},{"id":2727778,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T16:05:49.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":7500,"price":4.47,"value":33525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6298940,"source":{"system":"sec-edgar","filing":"0001493152-21-010480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010480/ownership.xml","form_type":"4/A","original_submission_date":"2021-05-04"}},{"id":2727777,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T16:05:49.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":5000,"price":3.95,"value":19750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6306440,"source":{"system":"sec-edgar","filing":"0001493152-21-010480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010480/ownership.xml","form_type":"4/A","original_submission_date":"2021-05-04"}},{"id":2727776,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T16:05:49.000Z","date":"2021-04-22","kind":"sale","acquired":false,"shares":5000,"price":3.52,"value":17600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6311440,"source":{"system":"sec-edgar","filing":"0001493152-21-010480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010480/ownership.xml","form_type":"4/A","original_submission_date":"2021-05-04"}},{"id":2730800,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:52:48.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":10000,"price":3.84,"value":38400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6288940,"source":{"system":"sec-edgar","filing":"0001493152-21-010442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010442/ownership.xml","form_type":"4"}},{"id":2730799,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:52:48.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":7500,"price":4.47,"value":33525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6298940,"source":{"system":"sec-edgar","filing":"0001493152-21-010442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010442/ownership.xml","form_type":"4"}},{"id":2730798,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:52:48.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":5000,"price":3.95,"value":19750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6306440,"source":{"system":"sec-edgar","filing":"0001493152-21-010442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010442/ownership.xml","form_type":"4"}},{"id":2730797,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:52:48.000Z","date":"2021-04-22","kind":"sale","acquired":false,"shares":5000,"price":3.52,"value":17600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6311440,"source":{"system":"sec-edgar","filing":"0001493152-21-010442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221010442/ownership.xml","form_type":"4"}},{"id":2758514,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T17:48:57.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":10000,"price":2.16,"value":21600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6316440,"source":{"system":"sec-edgar","filing":"0001493152-21-007950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221007950/ownership.xml","form_type":"4"}},{"id":2809327,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-04T21:06:22.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":10000,"price":2.31,"value":23100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6326440,"source":{"system":"sec-edgar","filing":"0001493152-21-005375","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221005375/ownership.xml","form_type":"4"}},{"id":2876944,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T15:47:48.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":10000,"price":2.04,"value":20400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6336440,"source":{"system":"sec-edgar","filing":"0001493152-21-002719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221002719/ownership.xml","form_type":"4"}},{"id":2921741,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:36:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":10000,"price":2.23,"value":22300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6346440,"source":{"system":"sec-edgar","filing":"0001493152-21-000241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315221000241/ownership.xml","form_type":"4"}},{"id":3006434,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":2,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":3,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-15T21:03:34.000Z","date":"2020-10-13","kind":"sale","acquired":false,"shares":10000,"price":2.97,"value":29700.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6356440,"source":{"system":"sec-edgar","filing":"0001493152-20-019507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315220019507/ownership.xml","form_type":"4"}},{"id":3274597,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T21:35:03.000Z","date":"2019-11-18","kind":"other","acquired":false,"shares":9350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6366440,"source":{"system":"sec-edgar","filing":"0001493152-20-002223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315220002223/ownership.xml","form_type":"5"}},{"id":3306625,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T21:54:09.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":10000,"price":2.97,"value":29700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold pursuant to 10X Fund, LP's Quarterly Liquidity Program."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6375790,"source":{"system":"sec-edgar","filing":"0001493152-20-000877","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315220000877/ownership.xml","form_type":"4"}},{"id":3393796,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-10-15T10:56:18.000Z","date":"2019-10-10","kind":"sale","acquired":false,"shares":17000,"price":3.725,"value":63325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold pursuant to 10X Fund, LP's Quarterly Liquidity Program."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6385790,"source":{"system":"sec-edgar","filing":"0001493152-19-015454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219015454/ownership.xml","form_type":"4"}},{"id":3393795,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-10-15T10:56:18.000Z","date":"2019-08-02","kind":"other","acquired":false,"shares":38690,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security pursuant to applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6402790,"source":{"system":"sec-edgar","filing":"0001493152-19-015454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219015454/ownership.xml","form_type":"4"}},{"id":3456160,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-07-25T10:03:45.000Z","date":"2019-07-15","kind":"other","acquired":false,"shares":306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security pursuant to applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security pursuant to applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6441480,"source":{"system":"sec-edgar","filing":"0001493152-19-011073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219011073/ownership.xml","form_type":"4"}},{"id":3492963,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-06-12T17:13:23.000Z","date":"2019-05-03","kind":"other","acquired":false,"shares":67515,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security under applicable law."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6441786,"source":{"system":"sec-edgar","filing":"0001493152-19-009040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219009040/ownership.xml","form_type":"4"}},{"id":3572559,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T22:02:42.000Z","date":"2018-09-30","kind":"other","acquired":true,"shares":38144,"price":6.03,"value":230008.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 9/30/2018. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9 and as an involuntary transaction pursuant to court decisions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 9/30/2018. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":2719955,"source":{"system":"sec-edgar","filing":"0001493152-19-004632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004632/ownership.xml","form_type":"5"}},{"id":3572558,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T22:02:42.000Z","date":"2018-06-30","kind":"other","acquired":true,"shares":31606,"price":7.28,"value":230091.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 6/30/2018. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9 and as an involuntary transaction pursuant to court decisions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 6/30/2018. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":2681811,"source":{"system":"sec-edgar","filing":"0001493152-19-004632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004632/ownership.xml","form_type":"5"}},{"id":3572557,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T22:02:42.000Z","date":"2018-03-31","kind":"other","acquired":true,"shares":48802,"price":4.72,"value":230345.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 3/31/2018. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9 and as an involuntary transaction pursuant to court decisions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 3/31/2018. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":3170205,"source":{"system":"sec-edgar","filing":"0001493152-19-004632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004632/ownership.xml","form_type":"5"}},{"id":3572556,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-3 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":1008000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.1238,"underlying":"Common Stock","underlying_shares":896997},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572555,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-3 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":1125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.4938,"underlying":"Common Stock","underlying_shares":753138},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572554,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-3 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":2.6938,"underlying":"Common Stock","underlying_shares":139211},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572553,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572552,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":103333},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572551,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":167500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":111667},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572550,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":108333},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572549,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":108333},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572548,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":103333},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572547,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":108333},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572546,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572545,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572544,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-2 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572543,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Series B-1 Preferred Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Conversion of Series B-1, B-2 and B-3 Convertible Preferred Stock into Common Stock. The Series B-1, B-2 and B-3 Convertible Preferred Stock was convertible at any time at the option of the holder, and was perpetual."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3,"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572542,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":true,"shares":896997,"price":1.1238,"value":1008045.2286,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":6509301,"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572541,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":true,"shares":753138,"price":1.4938,"value":1125037.5444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":5612304,"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572540,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":true,"shares":139211,"price":2.6938,"value":375006.5918,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":4859166,"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3572539,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"General Partner"}},{"id":71221,"kind":"person","name":"CZIRR JAMES C","position":3,"cik":"0001260641","reported_name":"CZIRR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of GP"}}],"security":"Common Stock","published_at":"2019-04-01T21:59:32.000Z","date":"2019-01-11","kind":"exercise","acquired":true,"shares":2000000,"price":3,"value":6000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-6."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":4719955,"source":{"system":"sec-edgar","filing":"0001493152-19-004630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315219004630/ownership.xml","form_type":"4"}},{"id":3887288,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T16:07:48.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":60000,"price":9.06,"value":543600.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2649786,"source":{"system":"sec-edgar","filing":"0001493152-18-009006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218009006/form4.xml","form_type":"4"}},{"id":3887287,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T16:07:48.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":15475,"price":8.47,"value":131073.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2709786,"source":{"system":"sec-edgar","filing":"0001493152-18-009006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218009006/form4.xml","form_type":"4"}},{"id":3887286,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T16:07:48.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":44525,"price":8.48,"value":377572.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2725261,"source":{"system":"sec-edgar","filing":"0001493152-18-009006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218009006/form4.xml","form_type":"4"}},{"id":3887285,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T16:07:48.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":31860,"price":7.99,"value":254561.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2769786,"source":{"system":"sec-edgar","filing":"0001493152-18-009006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218009006/form4.xml","form_type":"4"}},{"id":3894220,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-14T23:32:51.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":28140,"price":7.97,"value":224275.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2801646,"source":{"system":"sec-edgar","filing":"0001493152-18-008739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008739/form4.xml","form_type":"4"}},{"id":3894219,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-14T23:32:51.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":60000,"price":7.47,"value":448200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2829786,"source":{"system":"sec-edgar","filing":"0001493152-18-008739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008739/form4.xml","form_type":"4"}},{"id":3894218,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-14T23:32:51.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":60000,"price":7.09,"value":425400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2889786,"source":{"system":"sec-edgar","filing":"0001493152-18-008739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008739/form4.xml","form_type":"4"}},{"id":3894217,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-14T23:32:51.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":60000,"price":6.59,"value":395400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2949786,"source":{"system":"sec-edgar","filing":"0001493152-18-008739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008739/form4.xml","form_type":"4"}},{"id":3897152,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T22:30:55.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":60000,"price":6.08,"value":364800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3009786,"source":{"system":"sec-edgar","filing":"0001493152-18-008550","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008550/form4.xml","form_type":"4"}},{"id":3897151,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T22:30:55.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":50000,"price":5.64,"value":282000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3069786,"source":{"system":"sec-edgar","filing":"0001493152-18-008550","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008550/form4.xml","form_type":"4"}},{"id":3905879,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T20:51:24.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":8093,"price":5.13,"value":41517.09,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3119786,"source":{"system":"sec-edgar","filing":"0001493152-18-008235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008235/form4.xml","form_type":"4"}},{"id":3905878,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T20:51:24.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":41907,"price":5.12,"value":214563.84,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3161693,"source":{"system":"sec-edgar","filing":"0001493152-18-008235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218008235/form4.xml","form_type":"4"}},{"id":4072360,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T20:18:28.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":111149,"price":2.07,"value":230078.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 12/31/17. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9 and as an involuntary transaction pursuant to court decisions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 12/31/17. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3365428,"source":{"system":"sec-edgar","filing":"0001493152-18-001595","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218001595/form5.xml","form_type":"5"}},{"id":4072359,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T20:18:28.000Z","date":"2017-09-30","kind":"other","acquired":true,"shares":119129,"price":1.93,"value":229918.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 9/30/17. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9 and as an involuntary transaction pursuant to court decisions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 9/30/17. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3254279,"source":{"system":"sec-edgar","filing":"0001493152-18-001595","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218001595/form5.xml","form_type":"5"}},{"id":4086698,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-30T02:58:37.000Z","date":"2018-01-26","kind":"sale","acquired":false,"shares":39300,"price":5.35,"value":210255.0,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3120984,"source":{"system":"sec-edgar","filing":"0001493152-18-001223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218001223/form4.xml","form_type":"4"}},{"id":4086697,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-30T02:58:37.000Z","date":"2018-01-25","kind":"sale","acquired":false,"shares":205144,"price":5.45,"value":1118034.8,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3160284,"source":{"system":"sec-edgar","filing":"0001493152-18-001223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315218001223/form4.xml","form_type":"4"}},{"id":4213755,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:46:10.000Z","date":"2017-06-30","kind":"other","acquired":true,"shares":95205,"price":2.42,"value":230396.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 6/30/2017. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 6/30/2017. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3135150,"source":{"system":"sec-edgar","filing":"0001493152-17-010379","document":"form-4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010379/form-4.xml","form_type":"4"}},{"id":4213754,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:46:10.000Z","date":"2017-03-31","kind":"other","acquired":true,"shares":116151,"price":1.98,"value":229978.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 3/31/2017. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock received in satisfaction of $230,160 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was payable on 3/31/2017. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3039945,"source":{"system":"sec-edgar","filing":"0001493152-17-010379","document":"form-4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010379/form-4.xml","form_type":"4"}},{"id":4213752,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:40:48.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":211876,"price":1.01,"value":213994.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock received in satisfaction of $213,994.83 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock received in satisfaction of $213,994.83 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4/A amends a Form 4 originally filed 2/1/2017, which reported the receipt of 211,876 shares as a stock dividend, and is being filed to correct the number of shares owned after receipt of the dividend, which changed as the result of an amendment filed to correct erroneous information in a prior Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2923794,"source":{"system":"sec-edgar","filing":"0001493152-17-010375","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010375/form4a.xml","form_type":"4/A","original_submission_date":"2017-02-01"}},{"id":4213747,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:30:53.000Z","date":"2016-09-30","kind":"other","acquired":false,"shares":17295,"price":1.13,"value":19543.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distributed as an in-kind distribution to four withdrawing limited partners in 10X Fund, LP., which was effective as of 9/30/16. Transaction price is the closing market price on 9/30/16, although the actual transfer of the shares occurred later."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4/A amends a Form 4 originally filed 10/24/16, which reported the distribution of 229,383 shares to a withdrawing limited partner on 9/30/16, to correct the amounts of the distribution. The share distributions reported herein also include the share distributions reported in a Form 4 filed 11/15/16, which erroneously reported the distribution of 9,663 and 17,096 shares to a withdrawing limited partner on 11/10/16."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2711918,"source":{"system":"sec-edgar","filing":"0001493152-17-010369","document":"form4-a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010369/form4-a.xml","form_type":"4/A","original_submission_date":"2016-10-24"}},{"id":4213746,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:30:53.000Z","date":"2016-09-30","kind":"other","acquired":false,"shares":484036,"price":1.13,"value":546960.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distributed as an in-kind distribution to four withdrawing limited partners in 10X Fund, LP., which was effective as of 9/30/16. Transaction price is the closing market price on 9/30/16, although the actual transfer of the shares occurred later."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4/A amends a Form 4 originally filed 10/24/16, which reported the distribution of 229,383 shares to a withdrawing limited partner on 9/30/16, to correct the amounts of the distribution. The share distributions reported herein also include the share distributions reported in a Form 4 filed 11/15/16, which erroneously reported the distribution of 9,663 and 17,096 shares to a withdrawing limited partner on 11/10/16."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2729213,"source":{"system":"sec-edgar","filing":"0001493152-17-010369","document":"form4-a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010369/form4-a.xml","form_type":"4/A","original_submission_date":"2016-10-24"}},{"id":4213745,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:30:53.000Z","date":"2016-09-30","kind":"other","acquired":false,"shares":164110,"price":1.13,"value":185444.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distributed as an in-kind distribution to four withdrawing limited partners in 10X Fund, LP., which was effective as of 9/30/16. Transaction price is the closing market price on 9/30/16, although the actual transfer of the shares occurred later."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4/A amends a Form 4 originally filed 10/24/16, which reported the distribution of 229,383 shares to a withdrawing limited partner on 9/30/16, to correct the amounts of the distribution. The share distributions reported herein also include the share distributions reported in a Form 4 filed 11/15/16, which erroneously reported the distribution of 9,663 and 17,096 shares to a withdrawing limited partner on 11/10/16."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3213249,"source":{"system":"sec-edgar","filing":"0001493152-17-010369","document":"form4-a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010369/form4-a.xml","form_type":"4/A","original_submission_date":"2016-10-24"}},{"id":4213744,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T20:30:53.000Z","date":"2016-09-30","kind":"other","acquired":false,"shares":92451,"price":1.13,"value":104469.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distributed as an in-kind distribution to four withdrawing limited partners in 10X Fund, LP., which was effective as of 9/30/16. Transaction price is the closing market price on 9/30/16, although the actual transfer of the shares occurred later."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4/A amends a Form 4 originally filed 10/24/16, which reported the distribution of 229,383 shares to a withdrawing limited partner on 9/30/16, to correct the amounts of the distribution. The share distributions reported herein also include the share distributions reported in a Form 4 filed 11/15/16, which erroneously reported the distribution of 9,663 and 17,096 shares to a withdrawing limited partner on 11/10/16."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3377359,"source":{"system":"sec-edgar","filing":"0001493152-17-010369","document":"form4-a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217010369/form4-a.xml","form_type":"4/A","original_submission_date":"2016-10-24"}},{"id":4473683,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-01T18:59:27.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":211876,"price":1.01,"value":213994.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock received in satisfaction of $213,994.83 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock received in satisfaction of $213,994.83 of dividends due on Series B-1, B-2 and B-3 Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3452303,"source":{"system":"sec-edgar","filing":"0001493152-17-001000","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217001000/form4.xml","form_type":"4"}},{"id":4495284,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Lock-Up Warrant","published_at":"2017-01-09T22:24:27.000Z","date":"2016-12-23","kind":"purchase","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the Series B-3 Warrant and the Lock-Up Warrant is subject to downward adjustment based upon the subsequent agreement between the company and a lead investor."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 22, 2016, the company and 10X Fund, LP entered into a Lock-Up Agreement, under which the Company agreed to issue 10X Fund, L.P. Lock-Up Warrants to purchase 500,000 shares of common stock, plus additional Lock-Up Warrants to purchase 0.08333 shares of common stock for every $1 invested by 10X Fund, LP in the Company's Series B-3 Convertible Preferred Stock offering, up to a maximum of 500,000 warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":7,"derivative":{"exercise_price":3,"exercise_date":"2017-06-23","expiration_date":"2023-12-23","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001493152-17-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217000300/form4.xml","form_type":"4"}},{"id":4495283,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Lock-Up Warrant","published_at":"2017-01-09T22:24:27.000Z","date":"2016-12-23","kind":"purchase","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the Series B-3 Warrant and the Lock-Up Warrant is subject to downward adjustment based upon the subsequent agreement between the company and a lead investor."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2016, 10X Fund, L.P. purchased (a) 1,008,000 shares of Series B-3 Convertible Preferred Stock, (b) one Series B-3 Warrant to purchase 672,747 shares of common stock at 3.00 per share, and (c) one Lock-Up Warrant to purchase 168,033 shares of common stock at $3.00 per share, for total consideration of $1,008,000."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":6,"derivative":{"exercise_price":3,"exercise_date":"2017-06-23","expiration_date":"2023-12-23","underlying":"Common Stock","underlying_shares":168033},"source":{"system":"sec-edgar","filing":"0001493152-17-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217000300/form4.xml","form_type":"4"}},{"id":4495282,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-3 Warrant","published_at":"2017-01-09T22:24:27.000Z","date":"2016-12-23","kind":"purchase","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the Series B-3 Warrant and the Lock-Up Warrant is subject to downward adjustment based upon the subsequent agreement between the company and a lead investor."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2016, 10X Fund, L.P. purchased (a) 1,008,000 shares of Series B-3 Convertible Preferred Stock, (b) one Series B-3 Warrant to purchase 672,747 shares of common stock at 3.00 per share, and (c) one Lock-Up Warrant to purchase 168,033 shares of common stock at $3.00 per share, for total consideration of $1,008,000."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3,"derivative":{"exercise_price":3,"exercise_date":"2017-06-23","expiration_date":"2023-12-23","underlying":"Common Stock","underlying_shares":672747},"source":{"system":"sec-edgar","filing":"0001493152-17-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217000300/form4.xml","form_type":"4"}},{"id":4495281,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-3 Convertible Preferred Stock","published_at":"2017-01-09T22:24:27.000Z","date":"2016-12-23","kind":"purchase","acquired":true,"shares":1008000,"price":1,"value":1008000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2016, 10X Fund, L.P. purchased (a) 1,008,000 shares of Series B-3 Convertible Preferred Stock, (b) one Series B-3 Warrant to purchase 672,747 shares of common stock at 3.00 per share, and (c) one Lock-Up Warrant to purchase 168,033 shares of common stock at $3.00 per share, for total consideration of $1,008,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-3 Convertible Preferred Stock is convertible immediately into shares of Issuer's common stock at a conversion price equal to the market price of the common stock on the date of issuance of the Series B-3 Convertible Preferred Stock, plus $0.9375 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-3 Convertible Preferred Stock is convertible immediately into shares of Issuer's common stock at a conversion price equal to the market price of the common stock on the date of issuance of the Series B-3 Convertible Preferred Stock, plus $0.9375 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":2508000,"derivative":{"exercise_price":1.1237,"underlying":"Common Stock","underlying_shares":896997},"source":{"system":"sec-edgar","filing":"0001493152-17-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217000300/form4.xml","form_type":"4"}},{"id":4495280,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T21:55:45.000Z","date":"2016-09-30","kind":"other","acquired":true,"shares":84589,"price":2.13,"value":180174.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Common stock received in satisfaction of $180,000 of dividends due on Series B Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend. This Form 4/A amends the original filing to correct the price per share at which the dividend was paid in common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Common stock received in satisfaction of $180,000 of dividends due on Series B Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend. This Form 4/A amends the original filing to correct the price per share at which the dividend was paid in common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3469810,"source":{"system":"sec-edgar","filing":"0001493152-17-000292","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217000292/form4a.xml","form_type":"4/A","original_submission_date":"2016-10-24"}},{"id":4495279,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":71219,"kind":"organization","name":"10X Fund, L.P.","position":1,"cik":"0001453356","reported_name":"10X Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71220,"kind":"organization","name":"10X Capital Management, LLC","position":2,"cik":"0001457247","reported_name":"10X Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T21:55:45.000Z","date":"2016-06-30","kind":"other","acquired":true,"shares":124524,"price":1.45,"value":180559.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common stock received in satisfaction of $180,000 of dividends due on Series B Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend. This Form 4/A amends the original filing to correct the number of share issued in payment of the dividend, and to correct the price per share at which the dividend was paid in common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock received in satisfaction of $180,000 of dividends due on Series B Convertible Preferred Stock owned by 10X Fund, L.P. pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend. This Form 4/A amends the original filing to correct the number of share issued in payment of the dividend, and to correct the price per share at which the dividend was paid in common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":3385221,"source":{"system":"sec-edgar","filing":"0001493152-17-000292","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000149315217000292/form4a.xml","form_type":"4/A","original_submission_date":"2016-10-24"}}],"next_cursor":"2017-01-09T21:55:45.000000Z,4495279"}